{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:35:13Z","timestamp":1774928113759,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK32493"],"award-info":[{"award-number":["DK32493"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK32083"],"award-info":[{"award-number":["DK32083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK050979"],"award-info":[{"award-number":["DK050979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK57516"],"award-info":[{"award-number":["DK57516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["17-2013-535"],"award-info":[{"award-number":["17-2013-535"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jim.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T20:15:25Z","timestamp":1453493725000},"page":"28-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease"],"prefix":"10.1016","volume":"430","author":[{"given":"Zhiyuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Steck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Rewers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2016.01.011_bb0005","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1053\/j.gastro.2006.10.003","article-title":"AGA Institute Medical position statement on the diagnosis and management of celiac disease","volume":"131","author":"AGA Institute","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jim.2016.01.011_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1447.062","article-title":"The environmental determinants of diabetes in the young (TEDDY) study","volume":"1150","author":"Anon","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jim.2016.01.011_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2016.01.011_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/jaut.1999.0303","article-title":"One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies","volume":"13","author":"Bao","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jim.2016.01.011_bb0025","article-title":"Feasibility of screening for type 1 diabetes and celiac disease in a pediatric clinic setting","author":"Bautista","year":"2015","journal-title":"Pediatr. Diabetes"},{"issue":"9 Suppl. 4","key":"10.1016\/j.jim.2016.01.011_bb0030","first-page":"14","article-title":"Anti-gliadin antibodies identify celiac patients overlooked by tissue transglutaminase antibodies","volume":"72","author":"Benson","year":"2013","journal-title":"Hawaii J. Med. Public Health"},{"key":"10.1016\/j.jim.2016.01.011_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jim.2016.01.011_bb0040","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jc.2010-0293","article-title":"Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia","volume":"95","author":"Bonifacio","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jim.2016.01.011_bb0045","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc14-1140","article-title":"Type 1 diabetes through the life span: a position statement of the American Diabetes Association[J]","volume":"37","author":"Chiang","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study[J]","volume":"163","author":"Fasano","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jim.2016.01.011_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jim.2016.01.011_bb0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJMoa1313977","article-title":"Risk of pediatric celiac disease according to HLA haplotype and country","volume":"371","author":"Liu","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2016.01.011_bb0065","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1365-2036.2007.03502.x","article-title":"Increasing prevalence of coeliac disease over time","volume":"26","author":"Lohi","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jim.2016.01.011_bb0070","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.2337\/db13-0534","article-title":"GAD65 autoantibodies detected by electrochemiluminescence (ECL) assay identify high risk for type 1 diabetes","volume":"62","author":"Miao","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jim.2016.01.011_bb0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/dia.2014.0186","article-title":"The type 1 diabetes TrialNet study group. electrochemiluminescence assays for insulin and GAD autoantibodies improve prediction of type 1 diabetes risk","volume":"17","author":"Miao","year":"2014","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jim.2016.01.011_bb0080","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s00125-010-1915-5","article-title":"Diabetes antibody standardization program: evaluation of assays for insulin autoantibodies","volume":"53","author":"Schlosser","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jim.2016.01.011_bb0085","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.2337\/dc11-0981","article-title":"A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in diabetes prevention trial\u2014type 1 (DPT-1) participants","volume":"34","author":"Sosenko","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0090","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2337\/dc13-0425","article-title":"The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients","volume":"36","author":"Sosenko","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0095","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/dc10-2088","article-title":"Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young","volume":"34","author":"Steck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/dc10-1494","article-title":"Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood","volume":"34","author":"Vehik","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0105","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2337\/dc11-2081","article-title":"Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies","volume":"35","author":"Yu","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0115","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc12-2245","article-title":"Proinsulin\/insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity","volume":"36","author":"Yu","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jim.2016.01.011_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2337\/db11-0670","article-title":"Distinguishing persistent insulin autoantibodies with differential risk: non-radioactive bivalent proinsulin\/insulin autoantibody assay","volume":"61","author":"Yu","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jim.2016.01.011_bb0125","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.040556697","article-title":"Early expression of anti-insulin autoantibodies of man and the NOD mouse: evidence for early determination of subsequent diabetes","volume":"97","author":"Yu","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2016.01.011_bb0130","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916300102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916300102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:59:44Z","timestamp":1537045184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916300102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":25,"alternative-id":["S0022175916300102"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2016.01.011","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}